.
DIVISLAB financial statements
* Numbers in billions
| Capitalization * | 1 152 |
|---|---|
| EV * | 1 058 |
| Number of shares * | 0 |
| EPS | 74,75 |
| Revenue * | 69 |
| Net income * | 20 |
| Operating profit * | 26 |
| Total liabilities * | 15 |
| Net debt * | -20 |
| Total assets * | 108 |
| Equity * | 93 |
| Cash and investments * | 21 |
.
DIVISLAB valuation
| P/E | 58,05 |
|---|---|
| P/B | 12,39 |
| P/S | 16,80 |
| E/P | 2 |
| P/FCF | 111,12 |
.
DIVISLAB profitability
| ROE | 21% |
|---|---|
| ROA% | 18% |
| ROIC% | 27% |